216 related articles for article (PubMed ID: 8683313)
1. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.
Khalkhali I; Villanueva-Meyer J; Edell SL; Connolly JL; Schnitt SJ; Baum JK; Houlihan MJ; Jenkins RM; Haber SB
J Nucl Med; 2000 Dec; 41(12):1973-9. PubMed ID: 11138681
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
5. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
6. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer.
Krishnaiah G; Sher-Ahmed A; Ugwu-Dike M; Regan P; Singer J; Totoonchie A; Spiegler E; Sardi A
Breast J; 2003; 9(4):288-94. PubMed ID: 12846862
[TBL] [Abstract][Full Text] [Related]
8. Prone scintimammography in patients with suspicion of carcinoma of the breast.
Khalkhali I; Mena I; Jouanne E; Diggles L; Venegas R; Block J; Alle K; Klein S
J Am Coll Surg; 1994 May; 178(5):491-7. PubMed ID: 8167887
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide-guided stereotactic prebiopsy localization of nonpalpable breast lesions with normal mammograms.
Khalkhali I; Mishkin FS; Diggles LE; Klein SR
J Nucl Med; 1997 Jul; 38(7):1019-22. PubMed ID: 9225782
[TBL] [Abstract][Full Text] [Related]
10. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m sestamibi in the diagnosis of breast cancer. The Mayagüez Medical Center experience.
Farías-Jimenez J; Rivera A; Carlo VM
Bol Asoc Med P R; 2001; 93(1-12):9-11. PubMed ID: 12755069
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic accuracy of mammography and mammoscintigraphy in multifocal breast cancer].
Krivorot'ko PV
Vopr Onkol; 2013; 59(1):59-64. PubMed ID: 23805452
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women.
Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH
Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152
[TBL] [Abstract][Full Text] [Related]
14. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Brem RF; Floerke AC; Rapelyea JA; Teal C; Kelly T; Mathur V
Radiology; 2008 Jun; 247(3):651-7. PubMed ID: 18487533
[TBL] [Abstract][Full Text] [Related]
15. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses.
Klaus AJ; Klingensmith WC; Parker SH; Stavros AT; Sutherland JD; Aldrete KD
AJR Am J Roentgenol; 2000 Jun; 174(6):1779-83. PubMed ID: 10845522
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-MIBI scintimammography for suspicious breast lesions.
Palmedo H; Schomburg A; Grünwald F; Mallmann P; Krebs D; Biersack HJ
J Nucl Med; 1996 Apr; 37(4):626-30. PubMed ID: 8691253
[TBL] [Abstract][Full Text] [Related]
17. [The role of 99mTc-MIBI mammoscintigraphy in the diagnosis of breast cancer].
Ambrus E; Ormándi K; Séra T; Tószegi A; Csernay L; Pávics L
Orv Hetil; 1998 Jan; 139(4):183-7. PubMed ID: 9478054
[TBL] [Abstract][Full Text] [Related]
18. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
[TBL] [Abstract][Full Text] [Related]
19. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
20. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?
Alonso O; Massardo T; Delgado LB; Horvath J; Kabasakal L; Llamas-Olier A; Maunda KK; Morales R; Padhy AK; Shankar UR
J Nucl Med; 2001 Nov; 42(11):1614-21. PubMed ID: 11696629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]